HIPK2 Phosphorylates the Microtubule-Severing Enzyme Spastin at S268 for Abscission.
HIPK2
abscission
midbody
phosphorylation
spastin
Journal
Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052
Informations de publication
Date de publication:
05 07 2019
05 07 2019
Historique:
received:
30
05
2019
revised:
02
07
2019
accepted:
03
07
2019
entrez:
10
7
2019
pubmed:
10
7
2019
medline:
10
7
2019
Statut:
epublish
Résumé
Abscission is the final step of cell division, mediating the physical separation of the two daughter cells. A key player in this process is the microtubule-severing enzyme spastin that localizes at the midbody where its activity is crucial to cut microtubules and culminate the cytokinesis. Recently, we demonstrated that HIPK2, a multifunctional kinase involved in several cellular pathways, contributes to abscission and prevents tetraploidization. Here, we show that HIPK2 binds and phosphorylates spastin at serine 268. During cytokinesis, the midbody-localized spastin is phosphorylated at S268 in HIPK2-proficient cells. In contrast, no spastin is detectable at the midbody in HIPK2-depleted cells. The non-phosphorylatable spastin-S268A mutant does not localize at the midbody and cannot rescue HIPK2-depleted cells from abscission defects. In contrast, the phosphomimetic spastin-S268D mutant localizes at the midbody and restores successful abscission in the HIPK2-depleted cells. These results show that spastin is a novel target of HIPK2 and that HIPK2-mediated phosphorylation of spastin contributes to its midbody localization for successful abscission.
Identifiants
pubmed: 31284535
pii: cells8070684
doi: 10.3390/cells8070684
pmc: PMC6678495
pii:
doi:
Substances chimiques
Carrier Proteins
0
Serine
452VLY9402
HIPK2 protein, human
EC 2.7.1.-
Protein Serine-Threonine Kinases
EC 2.7.11.1
Spastin
EC 3.6.4.3
SPAST protein, human
EC 5.6.1.1
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
Hum Mol Genet. 2004 Sep 15;13(18):2121-32
pubmed: 15269182
Exp Cell Res. 2005 Oct 1;309(2):358-69
pubmed: 16026783
Cell Death Differ. 2006 Nov;13(11):1994-7
pubmed: 16729035
BMC Biol. 2008 Jul 09;6:31
pubmed: 18613979
Nat Struct Mol Biol. 2008 Dec;15(12):1278-86
pubmed: 18997780
Traffic. 2009 Jan;10(1):42-56
pubmed: 19000169
J Neurochem. 2009 Mar;108(5):1277-88
pubmed: 19141076
Nat Cell Biol. 2009 Apr;11(4):409-19
pubmed: 19287380
Hum Mol Genet. 2010 Jul 15;19(14):2767-79
pubmed: 20430936
Science. 2011 Mar 25;331(6024):1616-20
pubmed: 21310966
J Neurochem. 2011 May;117(4):724-34
pubmed: 21395583
Mol Biol Cell. 2012 Mar;23(6):1024-34
pubmed: 22278743
PLoS One. 2012;7(5):e36505
pubmed: 22574173
Mol Cell. 2012 Jul 13;47(1):87-98
pubmed: 22658722
J Exp Clin Cancer Res. 2012 Aug 13;31:63
pubmed: 22889244
J Mol Cell Biol. 2013 Feb;5(1):27-38
pubmed: 23000554
J Mol Biol. 2013 Jan 23;425(2):214-21
pubmed: 23178168
Biochim Biophys Acta. 2013 Jun;1833(6):1443-53
pubmed: 23485397
J Cell Biol. 2013 Aug 5;202(3):527-43
pubmed: 23897888
Dev Cell. 2014 Dec 8;31(5):525-38
pubmed: 25490264
Oncotarget. 2015 Apr 30;6(12):10320-34
pubmed: 25868975
PLoS Genet. 2015 Apr 13;11(4):e1005149
pubmed: 25875445
Semin Cell Dev Biol. 2016 May;53:57-63
pubmed: 26802517
Chromosoma. 2017 Feb;126(1):93-103
pubmed: 27106516
Trends Cell Biol. 2017 Jan;27(1):1-11
pubmed: 27810282
Cold Spring Harb Perspect Biol. 2017 Oct 3;9(10):null
pubmed: 28007751
Curr Top Dev Biol. 2017;123:73-103
pubmed: 28236976
Oncogene. 2017 Aug 24;36(34):4819-4827
pubmed: 28436952
Semin Cell Dev Biol. 2018 Feb;74:50-65
pubmed: 28843980
Protein Sci. 2018 Mar;27(3):725-737
pubmed: 29277937
Oncogene. 2018 Jun;37(26):3562-3574
pubmed: 29563611
Cell Rep. 2018 Aug 14;24(7):1756-1764
pubmed: 30110633
J Cell Biol. 2018 Dec 3;217(12):4057-4069
pubmed: 30373906
Dev Cell. 2018 Dec 3;47(5):547-563.e6
pubmed: 30513301